Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

May 26, 2021

Alexis Kim-Blanco Joins Barclay Damon

May 26, 2021—Barclay Damon announces Alexis Kim-Blanco, associate, has joined Barclay Damon’s Health Care Controversies, White Collar & Government Investigations, and Commercial Litigation Practice Areas. Her primary office location is Albany.

Kim-Blanco has experience handling health care-related disputes; high-stakes, complex contractual disputes; white collar criminal investigations, including tax fraud, wire fraud, and insider trading; regulatory proceedings brought by the SEC, DOJ, and FINRA; and internal investigations following allegations of securities fraud. Kim-Blanco has represented a wide range of financial institutions, public corporations, broker dealers, and asset management firms, including a “Big Four” accounting firm, a multimillion-dollar medical device company, a leading theme park and entertainment company, and one of the largest dialysis services providers in the United States.

Barclay Damon attorneys team across offices and practices to provide customized, targeted solutions grounded in industry knowledge and a deep understanding of our clients’ businesses. With nearly 300 attorneys, Barclay Damon is a leading law firm that operates from a strategic platform of offices located in the Northeastern United States and Toronto. For more information, visit our award-winning website at barclaydamon.com.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Massachusetts Federal Court Permits Sharing Clause in Protective Order in Products Liability Case

Alerts

NYS Court of Appeals Holds That Parent May Not Recover for Emotional Injuries in Prenatal-Injury Case

Alerts

Smarter Inventory Management for Pharmacies: Navigating Online Marketplace Compliance

Alerts

Emergency Wine Run, Now Legal: New York State Opens Retail-to-Retail Sales

Alerts

California's Updated Privacy Regulations: Automated Decisionmaking Technology, Cybersecurity Audits, and Risk Assessments, Part 1

Alerts

Pharmacies on High Alert: Optum Rx's 25-Percent Therapeutic-Class Cap Creates Major Legal, Operational, and Competitive Risks